January 25, 2010 Vol. XXVII, No. 4 Sign up for our FREE PW e-newsletter Home Past Issues Search Register Contact Us Back to Phys Weekly  Popular Articles  1. Managing COPD: An Update on GOLD Standards 2. Making the Case for Advanced Directives 3. Preventing MRSA Transmission  Making The Rounds   Clinical Update  Gender, Mortality, & Myocardial Infarction      Women, particularly those who are younger, appear to have experienced larger improvements in... Analyzing Aspirin’s Role in Diabetes      There appears to be no clear benefit of aspirin for the primary prevention of major... Analyzing Hospitalizations After HF      Mayo Clinic researchers have found that multiple hospitalizations appear to be common after a...  Medical Horizons  NDPH Rare Among the General Population      Norwegian investigators have found that new daily persistent headache (NDPH) in the general...  Through The Pipeline  New Indication for Type 2 Diabetes Drug      The FDA has approved an expanded indication for exenatide injection (Byetta, Amylin... This Week's Feature Story Preventing Occurrence of Microalbuminuria in Type 2 Diabetes      Data presented at Renal Week 2009 demonstrate that an angiotensin receptor blocker—olmesartan—appears to provide vascular protection in patients with type 2 diabetes by controlling blood pressure and delaying the occurrence of microalbuminuria. [ More ]  In The News  More Hope for Hypertension Therapies      A comparative analysis of ACE inhibitors and angiotensin receptor blockers has found that these drugs appear to be effective in treating stable ischemic heart disease, according to researchers at the AHRQ. The analysis, available at www.effectivehealthcare.ahrq.gov, notes that these therapies can lead to reductions in death, risk of heart attack, and risk of stroke. [ More ] NSAIDs, Mortality, & Colorectal Cancer      Researchers in California have found that NSAIDs appear to be associated with decreased mortality among women with colorectal cancer (CRC) when used regularly or over a prolonged duration before CRC diagnosis. When compared with no NSAID use, those who used these drugs regularly before a CRC diagnosis had improved overall survival (hazard ratio, 0.71) and CRC-specific survival (hazard ratio, 0.58) after adjusting for clinically relevant factors. [ More ] Improving Depression in Cancer Patients      A collaborative care program called IMPACT (Improving Mood-Promoting Access to Collaborative Treatment) appears to be feasible and effective for treating depression among older cancer patients in diverse primary care settings, according to investigators in Seattle. When assessed at 6 and 12 months, 55% and 39%, respectively, of patients participating in the IMPACT program had a 50% or greater reduction in depressive symptoms from baseline compared with 34% and 20% rates for usual care participants. [ More ]  In My Opinion...  Minimizing Distress in Children Before Surgery ZEEV N. KAIN, MD Professor & Chair Department of Anesthesiology and Perioperative Care Associate Dean for Clinical Research< >University of California, Irvine School of Medicine   To get Physician's Weekly posted in your hospital, click HERE PW Archives | Past Issues | Register | Contact Us | Search Archive | Back To Top © 2010 Physician’s Weekly, LLC Web design and development by Spindustry Interactive™

There is no survey at this time.